Skip to main content

Table 5 Results total Quality of Life (QOL) and QOL sub-scales

From: Yoga management of breast cancer-related lymphoedema: a randomised controlled pilot-trial

QOL

Group mean ± SD b-8

Between group changes 0-8

 

Group mean ± SD 8b-12

Between group changes 8b-12

Variable Gp(n)

Week 0 M ± SD

Week M ± SD

∆int-∆con 0–8 MD; (95% CI)

P(0–8)

Variable Gp(n)

Week 8b M ± SD

Week 12 M ± SD

∆int-∆con 8b-12 MD; (95% CI)

p(8b-12)

Total QOL

Con(11)

7.91 ± 1.22

7.45 ± 1.44

1.04; (-0.19 to 2.26)

0.437†

Con(10)

7.40 ± 1.51

7.40 ± 1.51

0.44; (-0.38 to 1.27)

0.290

Int(12)

6.83 ± 2.55

7.42 ± 1.24

Int(9)

7.33 ± 0.87

7.78 ± 1.09

Function

Con(11)

1.36 ± 0.40

1.30 ± 0.36

-0.13; (-0.34 to 0.09)

0.364†

Cont(10)

1.31 ± 0.38

1.35 ± 0.33

0.13; (-0.07 to 0.33)

0.210

Int(12)

1.48 ± 0.48

1.30 ± 0.31

Int(9)

1.34 ± 0.33

1.51 ± 0.14

Appearance

Con(11)

1.56 ± 0.81

1.56 ± 0.86

-0.07; (-0.34 to 0.20)

0.627

Con(10)

1.60 ± 0.69

1.60 ± 0.69

0.10; (-.25 to 0.45)

0.578

Int(11)

1.50 ± 0.34

1.43 ± 0.33

Int(9)

1.42 ± 0.37

1.52 ± 0.37

Symptoms

Con(11)

1.69 ± 0.37

1.82 ± 0.54

-0.44; (-0.74 tro -0.13)

0.038†

Con(10)

1.90 ± 0.49

1.73 ± 0.47

0.17; (-0.05 to 0.39)

0.124

Int(12)

2.11 ± 0.61

1.81 ± 0.40

Int(9)

1.91 ± 0.38

1.91 ± 0.40

Emotions

Con(11)

1.71 ± 0.56

1.61 ± 0.49

-0.18; (-0.62 to 0.26)

0.430

Con(10)

1.62 ± 0.52

1.60 ± 0.56

0.04; (-0.24 to 0.31)

0.801

Int(12)

1.86 ± 0.74

1.58 ± 0.7

Int(9)

1.44 ± 0.45

1.46 ± 0.43

  1. ∆ = change; Gp = Group; M ± SD = Mean ± Standard Deviation; MD = Mean Difference; CI = Confidence Interval.
  2. N = number.
  3. Con = control group; Int = intervention group.
  4. † = non-parametric analysis.
  5. 0 = baseline.